These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 111729)

  • 21. Clonal evolution of marker chromosomes in a case of myelofibrosis with myeloid metaplasia and myeloblastic transformation.
    Page BM; Watt JL; Reid IN; Davidson RJ; Walker W
    Acta Haematol; 1979; 61(6):301-9. PubMed ID: 115201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia.
    Reilly JT
    Semin Oncol; 2005 Aug; 32(4):359-64. PubMed ID: 16202681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple active X chromosomes in myelofibrosis with myeloid metaplasia.
    Van Dyke DL; Abraham JP; Maeda K; Weiss L; Poel M
    Cancer Genet Cytogenet; 1981 Mar; 3(2):137-44. PubMed ID: 7272992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic idiopathic myelofibrosis (CIMF) resulting from a unique 3;9 translocation disrupting the janus kinase 2 (JAK2) gene.
    Mark HF; Sotomayor EA; Nelson M; Chaves F; Sanger WG; Kaleem Z; Caughron SK
    Exp Mol Pathol; 2006 Dec; 81(3):217-23. PubMed ID: 16959246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic studies in five patients with myelofibrosis and myeloid metaplasia.
    Carbone P; Barbata G; Mirto S; Marcenò R; Leone S; Granata G
    Cancer Genet Cytogenet; 1984 Jul; 12(3):209-15. PubMed ID: 6722762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rh mosaicism and aberrant MNSs antigen expression in a patient with chronic myelogenous leukemia.
    Bracey AW; McGinniss MH; Levine RM; Whang-Peng J
    Am J Clin Pathol; 1983 Mar; 79(3):397-401. PubMed ID: 6402921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis.
    Jacobson RJ; Salo A; Fialkow PJ
    Blood; 1978 Feb; 51(2):189-94. PubMed ID: 620081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible cytogenetic marker associated with myelofibrosis in chronic granulocytic leukemia and its prognostic significance.
    Berman M; Knospe WH
    Cancer Genet Cytogenet; 1987 Apr; 25(2):361-5. PubMed ID: 3470122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia.
    Jones LC; Tefferi A; Idos GE; Kumagai T; Hofmann WK; Koeffler HP
    Oncogene; 2004 Oct; 23(47):7846-53. PubMed ID: 15361842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic myelofibrosis in blast transformation with 4;12 and 5;12 translocations and a 7q deletion.
    Przepiorka D; Bryant E; Kidd P
    Cancer Genet Cytogenet; 1988 Jan; 30(1):139-44. PubMed ID: 3422039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary myelofibrosis: when the clone manifests with Rh phenotype splitting.
    Orlando N; Putzulu R; Nuzzolo ER; Maresca M; Massini G; Capodimonti S; Zini G; Teofili L
    Ann Hematol; 2014 Jun; 93(6):1077-8. PubMed ID: 24149913
    [No Abstract]   [Full Text] [Related]  

  • 32. Chromosome deletion [46,XX,del(20)(q11)] in agnogenic myeloid metaplasia.
    Findley L; Kurnick JE; Peakman DC; Robinson A
    Hum Genet; 1979 Mar; 47(2):207-11. PubMed ID: 437786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation.
    Heim MU; Schleuning M; Eckstein R; Huhn D; Siegert W; Clemm C; Ledderose G; Kolb HJ; Wilmanns W; Mempel W
    Transfusion; 1988; 28(3):272-5. PubMed ID: 3130695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coincidence between fragile site expression and interstitial deletion of chromosome 11 in a case of myelofibrosis.
    Sessarego M; Ajmar F; Ravazzolo R; Bianchi Scarrà GL; Garrè C; Boccaccio P
    Hum Genet; 1983; 63(3):299-301. PubMed ID: 6852829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen Nou. A new high frequency Rh antigen.
    Habibi B; Perrier P; Salmon C
    Rev Fr Transfus Immunohematol; 1981 Feb; 24(1):117-20. PubMed ID: 6784228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunochemical characterization of rhesus proteins with antibodies raised against synthetic peptides.
    Hermand P; Mouro I; Huet M; Bloy C; Suyama K; Goldstein J; Cartron JP; Bailly P
    Blood; 1993 Jul; 82(2):669-76. PubMed ID: 8329720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel cytogenetic abnormality in primary myelofibrosis.
    Bae SY; Kim JS; Lee KN; Lee CK; Kim YK; Yoon SY; Lim CS; Cho YJ; Choi CW; Kim WY
    Cancer Genet Cytogenet; 2009 Oct; 194(1):65-6. PubMed ID: 19737657
    [No Abstract]   [Full Text] [Related]  

  • 38. A crossover or mutation in the Rh region revisited.
    Steinberg AG; Giblett ER; Lewis M; Zachary AA
    Am J Hum Genet; 1984 May; 36(3):700-3. PubMed ID: 6428223
    [No Abstract]   [Full Text] [Related]  

  • 39. Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis.
    Andrieux J; Roche-Lestienne C; Geffroy S; Desterke C; Grardel N; Plantier I; Selleslag D; Demory JL; Laï JL; Leleu X; Le Bousse-Kerdiles C; Vandenberghe P
    Cancer Genet Cytogenet; 2007 Oct; 178(1):11-6. PubMed ID: 17889703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translocation (2;3)(p21;q26) as the sole anomaly in a case of primary myelofibrosis.
    Herens C; Hermanne JP; Tassin F; Fassotte MF; Thiry A; Jamar M; Schaaf-Lafontaine N; Fillet G; Koulischer L
    Cancer Genet Cytogenet; 1999 Apr; 110(1):62-4. PubMed ID: 10198625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.